Çavuşoğlu, Y. Et Al. 2021. Prevalence of transthyretin cardiac amyloidosis with 99mTc-pyrophosphate (99mTc-PYP) cardiac scintigraphy in patients with heart failure and preserved ejection fraction. Heart Failure 2021 Online Congress , 95.

Çavuşoğlu, Y., Murat, S., Ak Sivrikoz, İ., & Yalvaç, H. E., (2021). Prevalence of transthyretin cardiac amyloidosis with 99mTc-pyrophosphate (99mTc-PYP) cardiac scintigraphy in patients with heart failure and preserved ejection fraction . Heart Failure 2021 Online Congress (pp.95).

Çavuşoğlu, YÜKSEL Et Al. "Prevalence of transthyretin cardiac amyloidosis with 99mTc-pyrophosphate (99mTc-PYP) cardiac scintigraphy in patients with heart failure and preserved ejection fraction," Heart Failure 2021 Online Congress, 2021

Çavuşoğlu, YÜKSEL Et Al. "Prevalence of transthyretin cardiac amyloidosis with 99mTc-pyrophosphate (99mTc-PYP) cardiac scintigraphy in patients with heart failure and preserved ejection fraction." Heart Failure 2021 Online Congress , pp.95, 2021

Çavuşoğlu, Y. Et Al. (2021) . "Prevalence of transthyretin cardiac amyloidosis with 99mTc-pyrophosphate (99mTc-PYP) cardiac scintigraphy in patients with heart failure and preserved ejection fraction." Heart Failure 2021 Online Congress , p.95.

@conferencepaper{conferencepaper, author={YÜKSEL ÇAVUŞOĞLU Et Al. }, title={Prevalence of transthyretin cardiac amyloidosis with 99mTc-pyrophosphate (99mTc-PYP) cardiac scintigraphy in patients with heart failure and preserved ejection fraction}, congress name={Heart Failure 2021 Online Congress}, city={}, country={}, year={2021}, pages={95} }